EllenRx® Prior Authorization Card

Ocrevus (ocrelizumab)

FDA-approved uses
MS
How it's given
IV infusion
Typical first approval
Up to 1 year (12 months)
Sources checked
2026-11-10

What payers commonly require

  • Confirmed MS of a type Ocrevus treatsPlans cover Ocrevus for relapsing MS or primary progressive MS, so your records should show which type you have.Source: Aetna, Cigna, UnitedHealthcare
  • Not taking another MS drug at the same timePlans will not pay for Ocrevus together with another long-term MS treatment.Source: Aetna, Cigna, UnitedHealthcare
  • Prescribed by or with a neurologistPlans want a neurologist or MS specialist to prescribe it or sign off on it.Source: Aetna, Cigna
  • Hepatitis B blood test before startingThe FDA label says everyone must be tested for hepatitis B before the first dose.Source: FDA label
  • Liver and antibody blood tests before startingThe FDA label says to check liver tests and antibody (immunoglobulin) levels before the first dose.Source: FDA label
  • For renewals: notes showing MS is stable or betterTo keep coverage, your doctor must show the drug is working for you.Source: Aetna, Cigna, UnitedHealthcare

Each plan has its own policy. Check the patient's plan before submitting.

Letter of medical necessity

Address each item above in the letter and attach the chart notes that show it: the diagnosis, prior treatments with dates and results, and any required test results.

Draft a letter with Ellen

Patients: see the Ocrevus patient page.

Sources: FDA label (DailyMed), Aetna (Last Review 10/14/2026), Cigna (Effective Date 08/15/2026), UnitedHealthcare (Effective Date January 1, 2026).

Not medical advice. For educational use by clinic staff. Ellen does not diagnose conditions or recommend treatments. Payer policies change often; confirm with the patient's plan.